Acute ST Elevation Myocardial Infarction Clinical Trial
Official title:
Does Sodium Nitrite Administration Reduce Ischaemia-reperfusion Injury in Patients Presenting With Acute ST Segment Elevation Myocardial Infarction?
The research question to be addressed is "Does a 2.5 - 5 minute systemic intravenous injection of sodium nitrite administered immediately before opening of the infarct related artery result in significant reduction of ischaemia reperfusion injury in patients with first acute ST elevation myocardial infarction (MI)?"
There are estimated to be 125,000 acute myocardial infarctions (heart attacks) in the UK
every year. Although substantial progress has been made in reducing the infarct size by
prompt opening of the infarct related artery (with thrombolytic therapy or percutaneous
coronary intervention (PCI)), effective therapy to further reduce the infarct size would
substantially reduce the risk of the patient subsequently developing heart failure.
There is a growing body of evidence from studies in animals that the use of nitrites may
help in reducing the infarct size, although this has not been tested in man.
In this phase 2/3 study, the investigators propose to investigate the effect of sodium
nitrite injection on infarct size. Eligible patients will be males aged 18 and over and
females aged 55 and over, presenting within 12 hours of the onset of chest pain, who are
suitable for treatment with percutaneous coronary intervention. Those who give verbal
agreement to take part will receive a 2.5-5 minute injection of sodium nitrite (or placebo)
immediately prior to the blocked artery being opened with percutaneous coronary
intervention.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00378352 -
REVEAL: Reduction of Infarct Expansion and Ventricular Remodeling With Erythropoietin After Large Myocardial Infarction
|
Phase 2 | |
Completed |
NCT02835534 -
The Efficacy and Safety of rhTNK-tPA in Comparison With Alteplase(Rt-PA) as Fibrinolytic Therapy of Acute STEMI
|
Phase 4 | |
Completed |
NCT01878487 -
Assessment of Lumen Expansion After Thrombus Extraction in Primary Percutaneous Coronary Intervention
|
N/A | |
Recruiting |
NCT00284323 -
Salvage: Postconditioning With Adenosine for STEMI
|
Phase 2 | |
Completed |
NCT01519518 -
How Effective Are Antithrombotic Therapies in Primary Percutaneous Coronary Intervention
|
Phase 4 |